AKT1 and non-small cell lung carcinoma: AKT, the core of the PI3K/AKT signaling pathway, has been found to be upregulated in its activated form (p-AKT) in 43–90% of NSCLC cases, and its expression in early primary tumors is often associated with poor prognosis [19, 20].